Lurbinectedin for extensive stage - small cell lung cancer (ES-SCLC): real world response patterns and survival outcomes.
Krayim B, Shalata W, Bar J, Moskovitz M, Rotem O, Urban D, Sorotsky HG, Kian W, Hanovich E, Marie R, Mann S, Gillis R, Basel A, Kornev G, Asna N, Peled N, Roisman LC.
Krayim B, et al. Among authors: basel a.
Lung Cancer. 2025 Jul;205:108598. doi: 10.1016/j.lungcan.2025.108598. Epub 2025 Jun 2.
Lung Cancer. 2025.
PMID: 40482375
Free article.